Virinchi Q1 FY27 Results: Revenue Falls 12% to Rs 70 Crore, Swings to Net Loss of Rs 2 Crore
- August 14, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Virinchi Q1 FY27: Revenue Rs 70 Cr (-12.04% YoY). Net loss Rs 2 Cr vs profit Rs 0.37 Cr. Gross profit Rs 1 Cr vs Rs 11 Cr (-88.32%). Consolidated. CMP Rs 15.17.
Quick Answer
Virinchi swung to a consolidated net loss of Rs 2 crore in Q1 FY27 from a profit of Rs 0.37 crore in Q1 FY26, with revenue declining 12.04% to Rs 70 crore. Gross profit collapsed 88% from Rs 11 crore to Rs 1 crore. Virinchi Q1 FY27 results reflect severe margin compression in the IT services and healthcare technology company, where direct project costs appear to have risen dramatically while revenue fell.
Virinchi Q1 FY27 results showed the Hyderabad-based IT services and healthcare technology company posting consolidated revenue of Rs 70 crore, down 12.04% from Rs 79 crore in Q1 FY26. The revenue decline reflects either project delays, reduced billing in IT services engagements, or lower healthcare technology implementations in the quarter.
The Virinchi Q1 FY27 results showed gross profit collapsing from Rs 11 crore to Rs 1 crore on 12% lower revenue — an 88% decline that points to either a dramatic increase in project delivery costs or a fundamental change in the revenue mix toward lower-margin services. This gross profit collapse, from approximately 13.9% margin to 1.4% margin, is one of the most severe seen across this results season.
Click Here – Get Free Investment Predictions
Virinchi Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Crore) | Q1 FY26 (Rs Crore) | YoY Change |
|---|---|---|---|
| Revenue | 70.00 | 79.00 | -12.04% |
| Gross Profit | 1.00 | 11.00 | -88.32% |
| Net Loss / PAT | -2.00 | 0.37 | -667.56% |
Virinchi Q1 FY27 Performance Analysis
Use the Univest Screener to track Virinchi live financials and Q1 FY27 results
Virinchi Q1 FY27 results are primarily characterised by the dramatic gross profit collapse from Rs 11 crore to Rs 1 crore. A 12% revenue decline should not produce an 88% gross profit decline in a well-managed IT services business. This extraordinary deterioration points to specific project-level cost overruns, subcontractor cost inflation, or the recognition of project losses in Q1 FY27.
The gross margin in Virinchi Q1 FY27 results fell from 13.9% (Rs 11 Cr on Rs 79 Cr) to 1.4% (Rs 1 Cr on Rs 70 Cr), a collapse of 12.5 percentage points. For an IT services and healthcare technology company, gross margins typically remain in the 25-40% range for established engagements. The 1.4% margin suggests either a major cost problem or a shift toward very low-margin pass-through projects.
The net loss of Rs 2 crore in Virinchi Q1 FY27 results, against a profit of Rs 0.37 crore, reflects the gross profit collapse flowing through to the bottom line. With only Rs 1 crore gross profit, the company cannot cover its fixed overhead costs including employee costs, rent, and administrative expenses.
Investors should treat Virinchi Q1 FY27 results with significant caution. The gross margin collapse requires a specific and credible explanation from management before the investment case can be reliably assessed.
Key Business Factors in Q1 FY27
Gross Profit Collapse — Project Costs
The gross margin deterioration from 13.9% to 1.4% in Virinchi Q1 FY27 results is extraordinary. Potential causes include fixed-price project cost overruns, large-scale subcontractor cost increases, recognition of project losses on contracts that were previously profitable, or a change in revenue mix.
Revenue Decline in IT Services
A 12% revenue decline in Virinchi Q1 FY27 results from Rs 79 crore to Rs 70 crore may reflect project completion timing gaps, client deferrals of IT spending, or the end of major contracts without immediate replacement. IT services revenue is characterised by lumpy project-based recognition.
Healthcare Technology Exposure
Virinchi operates in both IT services and healthcare technology. Any specific challenge in the healthcare technology implementation segment — regulatory delays, hospital budget freezes, or implementation timeline extensions — could disproportionately impact revenue and margin given the higher-margin nature of this business.
Dividend Details
Virinchi has not declared any dividend for Q1 FY27 given the net loss and gross profit collapse in the quarter. Dividend distributions would be inappropriate until profitability is restored.
FY27 Outlook
The FY27 outlook for Virinchi is uncertain following the Q1 FY27 results gross profit collapse. Management clarity on the specific causes of the margin deterioration is essential for assessing whether Q2 FY27 can show meaningful recovery.
If the gross profit collapse was driven by one-time project cost recognitions in Q1 FY27 results, the margin should normalise in Q2 FY27. If it reflects structural changes in the cost base or revenue mix, a more extended recovery period may be needed.
Virinchi Stock Performance
Download the Univest iOS App or Univest Android App to track Virinchi share price live and stay updated on quarterly results.
Virinchi shares traded at Rs 15.17 on August 13, 2026, down 0.20% on the day. The broadly flat stock price despite the dramatic Q1 FY27 results deterioration may reflect limited liquidity or market participants awaiting management commentary on the specific causes of the gross margin collapse.
Key Risks
Continued Gross Margin Weakness
If the gross profit of Rs 1 crore in Virinchi Q1 FY27 results does not recover significantly in Q2 FY27, the company will continue to report net losses, depleting cash reserves and potentially requiring external capital.
Project-Specific Cost Risk
If Virinchi has taken on loss-making fixed-price contracts that require continuing below-cost delivery through FY27, the gross margin recovery could be delayed beyond Q2, extending the loss trajectory.
Client and Revenue Concentration
IT services and healthcare technology companies with concentrated customer bases face high revenue volatility risk. Any client-level changes at Virinchi beyond what Q1 FY27 results show could further pressure revenues in subsequent quarters.
Conclusion
Virinchi Q1 FY27 results are significantly disappointing, with gross profit collapsing 88% from Rs 11 crore to Rs 1 crore on 12% lower revenue, swinging the company to a net loss of Rs 2 crore. This level of margin deterioration is unusual and requires specific management explanation.
Investors should seek clarity on the gross profit collapse before forming any investment view on Virinchi. Q2 FY27 results will be critical for determining whether the deterioration was temporary or more persistent. Consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Virinchi Q1 FY27 Results
When were Virinchi Q1 FY27 results announced?
Ans. Virinchi Q1 FY27 results were announced on August 13, 2026, covering the April to June 2026 quarter on a consolidated basis.
What was Virinchi’s revenue in Q1 FY27?
Ans. Virinchi reported consolidated revenue of Rs 70 crore in Q1 FY27, down 12.04% from Rs 79 crore in Q1 FY26.
Did Virinchi report a loss in Q1 FY27?
Ans. Yes, Virinchi Q1 FY27 results show a consolidated net loss of Rs 2 crore, reversing from a profit of Rs 0.37 crore in Q1 FY26.
Why did Virinchi’s gross profit collapse 88% in Q1 FY27?
Ans. Virinchi Q1 FY27 results show gross profit collapsing from Rs 11 crore to Rs 1 crore, far steeper than the 12% revenue decline. This likely reflects project cost overruns, subcontractor cost inflation, or recognition of project losses on fixed-price IT or healthcare technology contracts.
Did Virinchi declare a dividend after Q1 FY27 results?
Ans. Virinchi has not declared a dividend for Q1 FY27 given the net loss.
What is the outlook for Virinchi after Q1 FY27 results?
Ans. The FY27 outlook depends on management’s explanation of the gross margin collapse and the ability to recover margins in Q2. If one-time in nature, recovery is possible; if structural, the path is longer.
Is Virinchi a good investment after Q1 FY27 results?
Ans. Virinchi Q1 FY27 results show extreme margin deterioration and net losses. This warrants significant caution. Investors should await management commentary and Q2 FY27 results before investing. Consult a SEBI-registered advisor.
